SOST and osteoporosis: The crucial importance of sclerostin for bone formation is demonstrated by the excessive formation of bone in patients with von Buchems disease and sclerosteosis harboring loss-of-function mutations in the SOST gene (52, 53) and by the use of anti-sclerostin antibodies as an anabolic treatment for patients with osteoporosis (54, 55).